The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2007
DOI: 10.1016/j.hrthm.2007.03.008
|View full text |Cite
|
Sign up to set email alerts
|

Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: Antitachycardia pacing therapy during charging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
38
0
2

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(42 citation statements)
references
References 15 publications
2
38
0
2
Order By: Relevance
“…This is consistent with previous studies showing that dedicated ATP programming reduce the need for shocks to terminate VT/VF in a substantial number of patients [7,17,23]. In addition, newer devices are able to deliver ATP during energy charge when treating a VF episode, in an attempt to terminate a fast VT detected in the VF zone [24,25]. Interestingly, we observed no first shock failures following ineffective ATP therapies, both in DT+ and DTpatients, since all first shocks were programmed at maximum energy [23].…”
Section: Icd Therapy Efficacy In Dt+ Vs Dtpatientssupporting
confidence: 91%
See 1 more Smart Citation
“…This is consistent with previous studies showing that dedicated ATP programming reduce the need for shocks to terminate VT/VF in a substantial number of patients [7,17,23]. In addition, newer devices are able to deliver ATP during energy charge when treating a VF episode, in an attempt to terminate a fast VT detected in the VF zone [24,25]. Interestingly, we observed no first shock failures following ineffective ATP therapies, both in DT+ and DTpatients, since all first shocks were programmed at maximum energy [23].…”
Section: Icd Therapy Efficacy In Dt+ Vs Dtpatientssupporting
confidence: 91%
“…Patients in the DT+ group were followed for a longer period than DT-patients (32 vs. 15 [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] months; p < 0.001). After adjusting the event rate by the follow-up duration, there was no significant difference in the death rate per observation year (DT+: 0.04 vs. DT-: 0.04; p = 0.91) nor in the rate of patients with ventricular arrhythmic events per observation year (DT+: 0.10 vs. DT-: 0.12; p = 0.46) ( Table 2).…”
Section: Patients' Clinical Outcomesmentioning
confidence: 99%
“…Second, because shock confirmation after charging is less specific than the VT redetection after ATP, shocks are delivered after Ϸ5% of successful ATP sequences. 46,47 We believe that programming appropriate rate zones and different therapies for slow and faster ventricular arrhythmias would provide similar clinical benefit as ATP during charging. Nevertheless, if one decides to program ATP before shock delivery in faster 41 The pie charts show terminating therapy for FVT episodes in each arm.…”
Section: Therapy and Therapy-zone Boundariesmentioning
confidence: 99%
“…of ventricular arrhythmia events in repaired TOF patients. 2 Schoels et al showed that ATP could significantly terminate monomorphic VT more often than polymorphic VT. 17 Tuan et al showed that a smaller morphological variation, which means monomorphic VT, correlated with a higher probability of a successful ATP. 18 In the present study, >70% of the patients had β-blockers, and more than 40% of the patients had either amiodarone or sotalol.…”
Section: Overall Survivalmentioning
confidence: 99%